跳至主要内容
临床试验/CTRI/2020/11/028833
CTRI/2020/11/028833尚未招募2 期

Single arm clinical study to evaluate the effect of nagbala kshirpak in management of essential hypertension

Samkit Shah0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Systolic Blood Pressure: less than 170 mm of Hg more than or equal to 140 mm of Hg.
  • 2)Diastolic Blood Pressure: less than or equal to 110 mm of Hg or More than 90 mm of Hg.
  • 3)Patient willing to enroll in the research & to sign the consent form

排除标准

  • 1)Patient who have past history of atrial fibrillation, acute coronary syndrome, myocardial infarction, stroke or right ventricular hypertrophy, left ventricular hypertrophy, severe arrhythmia in last 6 months.
  • 2)Symptomatic patients with clinical features of early heart failure.
  • 3)Secondary hypertension.
  • 4)Women who are pregnant and lactating or on estrogen replacement therapy.
  • 5)Alcoholics and drug abusers.
  • 6)Accelerated and malignant hypertension.

研究者

发起方
Samkit Shah

相似试验